Literature DB >> 3094090

Androgenic status and sexual function in males with rheumatoid arthritis and ankylosing spondylitis.

D Gordon, G H Beastall, J A Thomson, R D Sturrock.   

Abstract

The pituitary-testicular axis was investigated in 31 males with rheumatoid arthritis (age range 19-60 years, median 55 years) and 33 males with ankylosing spondylitis (age range 22-55 years, median 37 years) and compared with a control group of 95 normal male volunteers. Using analysis of covariance, patients with rheumatoid arthritis showed significantly lower serum testosterone (p less than 0.05) and derived free testosterone (p less than 0.01) concentrations and significantly higher serum LH and FSH concentrations (p less than 0.05) compared with controls. All patients had normal serum prolactin and cortisol concentrations. Serum testosterone correlated with ESR, haemoglobin concentrations and rheumatoid factor titres (r = -0.448, p less than 0.02; r = 0.440, p less than 0.02; r = -0.360, p less than 0.05 respectively) in the rheumatoid patients. Although there was a significant negative correlation between ESR and haemoglobin concentrations (p less than 0.005) in the patients with ankylosing spondylitis, neither variable correlated with serum testosterone concentrations. There was no association between testicular dysfunction and the presence of extra-articular features of rheumatoid arthritis. Ten patients (33 per cent) with rheumatoid arthritis and four (13 per cent) with ankylosing spondylitis admitted to periods of impotence while 15 (50 per cent) of the former and 12 (39 per cent) of the latter had periods of decreased libido. There was no evidence for increased rates of infertility in either group.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094090

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  25 in total

Review 1.  Hypophyseal-pituitary-adrenal axis in autoimmune and rheumatic diseases.

Authors:  B H Athreya; P Rettig; W V Williams
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

2.  Low free testosterone levels in rheumatoid arthritis.

Authors:  T D Spector; L A Perry; G Tubb; A J Silman; E C Huskisson
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

3.  A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis. Correlation with disease activity.

Authors:  L Mirone; L Altomonte; P D'Agostino; A Zoli; A Barini; M Magaro
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

4.  Free and serum testosterone levels in 276 males: a comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls.

Authors:  T D Spector; W Ollier; L A Perry; A J Silman; P W Thompson; A Edwards
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

Review 5.  Sex ratios and hormones in HLA related rheumatic diseases.

Authors:  W H James
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

6.  Ankylosing spondylitis and the risk of cancer.

Authors:  Chih-Cheng Chang; Cheng-Wei Chang; Phung-Anh Alex Nguyen; Tzu-Hao Chang; Ya-Ling Shih; Wen-Ying Chang; Jorng-Tzong Horng; Oscar Kuang-Sheng Lee; Jennifer Hui-Chun Ho
Journal:  Oncol Lett       Date:  2017-06-09       Impact factor: 2.967

7.  Sexual functioning of people with rheumatoid arthritis: a multicenter study.

Authors:  Willy T M van Berlo; Harry B M van de Wiel; Erik Taal; Johannes J Rasker; Willibrord C M Weijmar Schultz; Martin H van Rijswijk
Journal:  Clin Rheumatol       Date:  2006-03-01       Impact factor: 2.980

8.  Rheumatoid arthritis, the contraceptive pill, and androgens.

Authors:  W H James
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

9.  Effects of androgens in models of rheumatoid arthritis.

Authors:  A Steward; D L Bayley
Journal:  Agents Actions       Date:  1992-03

10.  Sexual problems in male ankylosing spondylitis patients: relationship with functionality, disease activity, quality of life, and emotional status.

Authors:  Engin Cakar; Umit Dincer; Mehmet Zeki Kiralp; Mehmet Ali Taskaynatan; Evren Yasar; Emine Ozgur Bayman; Ahmet Ozgul; Hasan Dursun
Journal:  Clin Rheumatol       Date:  2007-02-07       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.